ScholarLens Back to search
2005•Journal of medical imagingRequires access

Evaluation of hepatic artery chemoembolization combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma

Lin Li

Open publisher page 0 citations

Abstract

Objective:To study the practical significance of the combined application of the transcatheter hepatic artery chemoembolization (TACE) and the percutaneous ethanol injection (PEI) in the treatment of hepatocellular carcinoma.Methods:From August 1999 to October 2001, 78 HCC patients were treated with interventional methods, among which TACE alone in group 1(41 cases),and combined TACE with PEI in group 2(37 cases). All patients were examined by CT and determined by AFP. The objective results were observed.Results:The CR+PR in group I was 35.3%, the rate of the decline of the AFP was 56.1% and 2～year survival was 50%,while respectively was 64.5% ,78.6% and 61.3% in group 2 (P0 05).Conclusion:It is certain that the combined application of TACE with PEI to treat HCC is much better than TACE alone.

About this research paper

What this paper is about

Objective:To study the practical significance of the combined application of the transcatheter hepatic artery chemoembolization (TACE) and the percutaneous ethanol injection (PEI) in the treatment of hepatocellular carcinoma.Methods:From August 1999 to October 2001, 78 HCC patients were treated with interventional methods, among which TACE alone in group 1(41 cases),and combined TACE with PEI in group 2(37 cases). All patients were examined by CT and determined by AFP. The objective results were observed.Results:The CR+PR in group I was 35.3%, the rate of the decline of the AFP was 56.1% and 2～year survival was 50%,while respectively was 64.5% ,78.6% and 61.3% in group 2 (P0 05).Conclusion:It is certain that the combined application of TACE with PEI to treat HCC is much better than TACE alone.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the practical significance of the combined application of the transcatheter hepatic artery chemoembolization (TACE) and the percutaneous ethanol injection (PEI) in the treatment of hepatocellular carcinoma.Methods:From August 1999 to October 2001, 78 HCC patients were treated with interventional methods, among which TACE alone in group 1(41 cases),and combined TACE with PEI in group 2(37 cases). All patients were examined by CT and determined by AFP. The objective results were observed.Results:The CR+PR in group I was 35.3%, the rate of the decline of the AFP was 56.1% and 2～year survival was 50%,while respectively was 64.5% ,78.6% and 61.3% in group 2 (P0 05).Conclusion:It is certain that the combined application of TACE with PEI to treat HCC is much better than TACE alone.

Key concepts: Medicine, Percutaneous ethanol injection, Hepatocellular carcinoma, Percutaneous, Transcatheter arterial chemoembolization, Radiology, Artery, Gastroenterology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Evaluation of hepatic artery chemoembolization combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma — Research Paper | ScholarLens